04/29/2026
Biologics and biosimilars are often grouped together. but they’re not exactly the same.
In uveitis care, biologics like adalimumab (Humira) and infliximab (Remicade) can play a critical role in controlling inflammation and protecting vision. But understanding how they’re developed, approved, and how they may work for you matters, especially as more patients are being asked to switch to biosimilars.
Knowledge is power when it comes to your care. ✨